1. Home
  2. BCLI vs ASNS Comparison

BCLI vs ASNS Comparison

Compare BCLI & ASNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • ASNS
  • Stock Information
  • Founded
  • BCLI 2000
  • ASNS 1998
  • Country
  • BCLI United States
  • ASNS United States
  • Employees
  • BCLI N/A
  • ASNS N/A
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • ASNS Telecommunications Equipment
  • Sector
  • BCLI Health Care
  • ASNS Telecommunications
  • Exchange
  • BCLI Nasdaq
  • ASNS Nasdaq
  • Market Cap
  • BCLI 9.1M
  • ASNS 7.9M
  • IPO Year
  • BCLI N/A
  • ASNS 2022
  • Fundamental
  • Price
  • BCLI $2.25
  • ASNS $1.05
  • Analyst Decision
  • BCLI Strong Buy
  • ASNS
  • Analyst Count
  • BCLI 1
  • ASNS 0
  • Target Price
  • BCLI $30.00
  • ASNS N/A
  • AVG Volume (30 Days)
  • BCLI 112.8K
  • ASNS 170.9K
  • Earning Date
  • BCLI 11-14-2024
  • ASNS 11-14-2024
  • Dividend Yield
  • BCLI N/A
  • ASNS N/A
  • EPS Growth
  • BCLI N/A
  • ASNS N/A
  • EPS
  • BCLI N/A
  • ASNS N/A
  • Revenue
  • BCLI N/A
  • ASNS $7,715,000.00
  • Revenue This Year
  • BCLI N/A
  • ASNS N/A
  • Revenue Next Year
  • BCLI N/A
  • ASNS N/A
  • P/E Ratio
  • BCLI N/A
  • ASNS N/A
  • Revenue Growth
  • BCLI N/A
  • ASNS 8.31
  • 52 Week Low
  • BCLI $1.05
  • ASNS $0.36
  • 52 Week High
  • BCLI $11.85
  • ASNS $4.60
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 70.03
  • ASNS 31.13
  • Support Level
  • BCLI $1.45
  • ASNS $1.13
  • Resistance Level
  • BCLI $1.72
  • ASNS $1.20
  • Average True Range (ATR)
  • BCLI 0.18
  • ASNS 0.06
  • MACD
  • BCLI 0.08
  • ASNS -0.01
  • Stochastic Oscillator
  • BCLI 84.69
  • ASNS 0.00

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The Company operates as one operating segment developing and marketing access broadband equipment for copper and fiber networks.

Share on Social Networks: